Exogenous lung surfactant: effect on radiographic appearance in premature infants.
- 1 October 1987
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 165 (1) , 11-13
- https://doi.org/10.1148/radiology.165.1.3306780
Abstract
At birth, premature infants of 25-29 weeks gestation, at high risk for development of neonatal respiratory distress syndrome (RDS), were given a single dose (90 mg) of calf lung surfactant extract (CLSE) by intratracheal instillation. The frequency and severity of RDS were assessed with use of a simple radiographic scoring system in which pulmonary parenchymal densities and the prominence of the air-bronchogram effect were used as indicators of widespread atelectasis. Radiographs were obtained in surfactant-treated and control infants within the first 90 minutes of life as part of an initial evaluation of their pulmonary status. Subsequent examinations were performed at less than 24 hours and less than 48 hours of age. Radiographic assessment of lung disease compared consistently with coordinated data on oxygen and mean airway pressure requirements of the infants. Both indicated a significantly decreased frequency and severity of RDS in the infants treated with surfactant. The results provide supporting evidence of the effectiveness of exogenous lung surfactant replacement in mitigating RDS in very premature infants.This publication has 3 references indexed in Scilit:
- Respiratory distress syndrome treated with human surfactant: radiographic findings.Radiology, 1985
- Lung Surfactant Replacement in Premature Lambs with Extracted Lipids from Bovine Lung Lavage: Effects of Dose, Dispersion Technique, and Gestational AgePediatric Research, 1985
- Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trialThe Journal of Pediatrics, 1985